Well.... I continue to be miffed at the deal Sprott pulled. Yes... they were smart about it, but... it stings considering the huge profit they are generating off EMR shareholders. A double shame they cannot close out the gold participation (should have had some sort of buy back option, hindsight of course). Refinancing might make sense, though, with the other debt facility, its probably not a priority.
The acquisition loan has been sitting there for a long time now. Perhaps part of the hold up, is EMR not being net cash, as in, needing a little extra fire-power to close out any deal.
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.22 |
Change
0.030(0.72%) |
Mkt cap ! $2.772B | |||
| Open | High | Low | Value | Volume |
| $4.18 | $4.22 | $4.15 | $4.461M | 1.063M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8689 | $4.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.22 | 18710 | 7 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| EMR (ASX) Chart |